CIPLA vs ULTRACEMCO: Stock Comparison

Cipla Ltd vs UltraTech Cement LtdUpdated 24 Aug 26, 4:08 PM ISTNSE & company filings

UltraTech Cement Ltd is the larger company by market capitalisation. Cipla Ltd shows a lower P/E, a higher ROE and lower leverage, while UltraTech Cement Ltd shows a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CIPLA leads 7; ULTRACEMCO leads 6 of 13

Not a rating
These companies operate in different sectors (Healthcare vs Construction Materials). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CIPLAULTRACEMCO

Valuation lens

What price are you paying?

Market CapContext only
₹1,16,16,120.67 L Cr
₹3,38,41,274.81 L Cr
P/E RatioCIPLA has the lower reading
34.39x
39.76x
P/B RatioCIPLA has the lower reading
3.37x
4.43x
EPSULTRACEMCO has the higher reading
₹41.84
₹290.41
Book ValueContext only
₹426.25
₹2,605.1
Dividend YieldULTRACEMCO has the higher reading
0.91%
2.07%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ULTRACEMCO is the larger company
₹3,38,41,274.81 L Cr vs ₹1,16,16,120.67 L Cr
P/E Ratio
CIPLA has a lower P/E
34.39x vs 39.76x
P/B Ratio
CIPLA has a lower P/B
3.37x vs 4.43x
EPS
ULTRACEMCO has higher earnings per share
₹290.41 vs ₹41.84
Dividend Yield
ULTRACEMCO has a higher dividend yield
2.07% vs 0.91%
Revenue Growth (TTM YoY)
ULTRACEMCO has faster revenue growth
3% vs -2.1%
EPS Growth (TTM YoY)
ULTRACEMCO has faster EPS growth
45.3% vs -54.6%
Qtr Sales Growth
ULTRACEMCO has stronger quarterly sales growth
15.8% vs -2.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCIPLAULTRACEMCO
SectorHealthcareConstruction Materials
IndustryPharmaceuticalsCement & Cement Products

Price

MetricCIPLAULTRACEMCO
Live Price₹1,437.9₹11,504
Day Change0.4%-0.57%
Volume12.21 L2.98 L
52-Week High₹1,673₹13,110
52-Week Low₹1,165.7₹10,325
Distance from 52W High-14.05%-12.25%

Valuation

MetricCIPLAULTRACEMCO
Market Cap₹1,16,16,120.67 L Cr₹3,38,41,274.81 L Cr
P/E Ratio34.39x39.76x
P/B Ratio3.37x4.43x
EPS₹41.84₹290.41
Book Value₹426.25₹2,605.1
Dividend Yield0.91%2.07%

Growth

MetricCIPLAULTRACEMCO
Revenue Growth (TTM YoY)-2.1%3%
EPS Growth (TTM YoY)-54.6%45.3%
Qtr Sales Growth-2.8%15.8%
Qtr Profit Growth-54.6%15.8%

Profitability & Leverage

MetricCIPLAULTRACEMCO
ROE11.6%11.1%
ROCE15.5%12.7%
Net Margin13.96%10.24%
Operating Margin20.9%19.2%
Debt to Equity0.02x0.31x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCIPLAULTRACEMCO
Promoter Holding9.17%58.4%
FII Holding20.21% 2.35 pp12.86% 1.25 pp
DII Holding34.63% 2.66 pp19.69% 1.27 pp
Public Holding15.94% 0.31 pp7.91%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Cipla Ltd and UltraTech Cement Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.